Skip to main content

Table 1 TCT diagnosis of cervical epithelial cells in control and study groups

From: The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study

Pathologic diagnosis Number NILM ASCUS LSIL HSIL SCC
Control group 40 37 (92.5) 3 (7.5) 0 (0.0) 0 (0.0) 0 (0.0)
Study group 151      
CIN I 27 2 (7.4) 7 (25.9) 11 (40.8) 7 (25.9) 0 (0.0)
CIN II/III 54 0 (0.0) 7 (12.9) 21 (38.9) 26 (48.2) 0 (0.0)
Carcinoma in situ 17 0 (0.0) 4 (23.5) 2 (11.8) 11 (64.7) 0 (0.0)
Invasive Carcinoma 28 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 28 (100.0)
CIN LEEP post-treatment 11 7 (63.6) 4 (36.4) 0 (0.0) 0 (0.0) 0 (0.0)
Cervical cancer post-treatment 14 7 (50.0) 7 (50.0) 0 (0.0) 0 (0.0) 0 (0.0)
  1. Results presented as number (%). TCT, thinprep cytologic test; Number, number of cases; NILM, negative for intraepithelial lesion or malignancy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma; CIN, cervical intraepithelial neoplasia; LEEP, loop electrical excision procedure.